The Joint Corp. (JYNT): Price and Financial Metrics

The Joint Corp. (JYNT): $9.26

0.47 (+5.35%)

POWR Rating

Component Grades








Add JYNT to Watchlist
Sign Up

Industry: Medical - Services




#30 of 65

in industry

JYNT Price/Volume Stats

Current price $9.26 52-week high $20.00
Prev. close $8.79 52-week low $7.31
Day low $8.76 Volume 137,000
Day high $9.28 Avg. volume 139,583
50-day MA $8.46 Dividend yield N/A
200-day MA $12.43 Market Cap 136.62M

JYNT Stock Price Chart Interactive Chart >


  • Quality is the dimension where JYNT ranks best; there it ranks ahead of 93.11% of US stocks.
  • The strongest trend for JYNT is in Sentiment, which has been heading down over the past 177 days.
  • JYNT ranks lowest in Sentiment; there it ranks in the 19th percentile.

JYNT Stock Summary

  • With a price/earnings ratio of 49.73, JOINT CORP P/E ratio is greater than that of about 88.15% of stocks in our set with positive earnings.
  • Of note is the ratio of JOINT CORP's sales and general administrative expense to its total operating expenses; 85.84% of US stocks have a lower such ratio.
  • In terms of twelve month growth in earnings before interest and taxes, JOINT CORP is reporting a growth rate of 96.5%; that's higher than 88.85% of US stocks.
  • Stocks that are quantitatively similar to JYNT, based on their financial statements, market capitalization, and price volatility, are KELYA, JJSF, ANF, BGFV, and GO.
  • Visit JYNT's SEC page to see the company's official filings. To visit the company's web site, go to

JYNT Valuation Summary

  • JYNT's price/earnings ratio is 47.2; this is 94.24% higher than that of the median Healthcare stock.
  • JYNT's price/sales ratio has moved down 8.5 over the prior 109 months.

Below are key valuation metrics over time for JYNT.

Stock Date P/S P/B P/E EV/EBIT
JYNT 2023-11-03 1 3.3 47.2 42.0
JYNT 2023-11-02 1 3.2 45.4 40.5
JYNT 2023-11-01 1 3.1 45.0 40.2
JYNT 2023-10-31 1 3.2 46.7 41.6
JYNT 2023-10-30 1 3.2 45.9 41.0
JYNT 2023-10-27 1 3.3 47.2 42.0

JYNT Growth Metrics

    The year over year revenue growth rate now stands at 37.01%.
  • Its 3 year net cashflow from operations growth rate is now at 125.56%.
  • The 3 year cash and equivalents growth rate now stands at 129.9%.
Over the past 33 months, JYNT's revenue has gone up $47,749,226.

The table below shows JYNT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 96.20013 8.463608 0.270077
2022-06-30 90.58875 7.683411 1.716059
2022-03-31 85.75023 13.40921 4.055279
2021-12-31 80.85965 15.23278 6.57577
2021-09-30 75.79653 16.72738 17.56817
2021-06-30 70.21546 17.16138 17.23503

JYNT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • JYNT has a Quality Grade of A, ranking ahead of 95.69% of graded US stocks.
  • JYNT's asset turnover comes in at 1.069 -- ranking 12th of 443 Trading stocks.
  • ADC, REFR, and MAA are the stocks whose asset turnover ratios are most correlated with JYNT.

The table below shows JYNT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.069 0.894 0.218
2021-03-31 1.068 0.892 0.189
2020-12-31 1.098 0.889 0.164
2020-09-30 1.158 0.888 0.130
2020-06-30 1.164 0.888 0.097
2020-03-31 1.222 0.886 0.115

JYNT Price Target

For more insight on analysts targets of JYNT, see our JYNT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $124.60 Average Broker Recommendation 1.58 (Moderate Buy)

The Joint Corp. (JYNT) Company Bio

The Joint Corp. develops, owns, operates, franchises, supports, and manages chiropractic clinics in the United States. The company was founded in 2010 and is based in Scottsdale, Arizona.

JYNT Latest News Stream

Event/Time News Detail
Loading, please wait...

JYNT Latest Social Stream

Loading social stream, please wait...

View Full JYNT Social Stream

Latest JYNT News From Around the Web

Below are the latest news stories about JOINT CORP that investors may wish to consider to help them evaluate JYNT as an investment opportunity.

Is There Now An Opportunity In The Joint Corp. (NASDAQ:JYNT)?

The Joint Corp. ( NASDAQ:JYNT ), is not the largest company out there, but it saw a double-digit share price rise of...

Yahoo | November 15, 2023

The Joint Chiropractic Announces its "Back Friday" Deal

Many Americans experience an influx of stress and anxiety as the holidays approach. Between putting up seasonal decorations, traveling long distances, and endless cooking, there are a lot of physical, mental, and chemical stressors that may lead to aches and pains. To support overall health during this busy time of the year, The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced today its "Back Friday" offering.

Yahoo | November 13, 2023

The Joint Corp. (NASDAQ:JYNT) Q3 2023 Earnings Call Transcript

The Joint Corp. (NASDAQ:JYNT) Q3 2023 Earnings Call Transcript November 9, 2023 The Joint Corp. misses on earnings expectations. Reported EPS is $-0.05 EPS, expectations were $0.04. Operator: Good day, and welcome to The Joint Corp. Third Quarter 2023 Financial Results Conference Call. [Operator Instructions]. Please note this event is being recorded. I would now […]

Yahoo | November 10, 2023

The Joint Corp. Reports Third Quarter 2023 Financial Results

- Reaffirms 2023 Financial and Clinic Opening Guidance -- Unveils Plan to Convert the Majority of the Corporate Portfolio Clinics to Franchised Clinics - SCOTTSDALE, Ariz., Nov. 09, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, reported its financial results for the quarter ended September 30, 2023. Financial Highlights: Q3 2023 Compared to Q3 2022 Grew revenue by 11% to $29.5 million.Reported operating loss of $898

Yahoo | November 9, 2023

The Joint Corp. Welcomes Jeff Gramm to the Board of Directors and Signs Standstill Agreement with Bandera Partners LLC

SCOTTSDALE, Ariz., Nov. 08, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care through The Joint Chiropractic® network, will appoint Jeff Gramm to the board of directors, effective January 2, 2024 and nominate him for election to the board at the company’s 2024 Annual Meeting of shareholders. Gramm fills a vacated seat, and the current board size remains at seven. The Joint’s lead director Matthew E. Rubel said, “We warmly welcome Jeff to

Yahoo | November 8, 2023

Read More 'JYNT' Stories Here

JYNT Price Returns

1-mo 22.97%
3-mo -1.70%
6-mo -33.14%
1-year -40.72%
3-year -64.21%
5-year 19.48%
YTD -33.76%
2022 -78.72%
2021 150.15%
2020 62.70%
2019 93.99%
2018 67.74%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!